News tagged with tyrosine kinase

Osimertinib bests platinum-pemetrexed in T790M+ NSCLC

(HealthDay)—Osimertinib is more effective than platinum-pemetrexed therapy in patients with T790M-positive advanced non-small-cell lung cancer whose disease has progressed during first-line epidermal growth factor receptor ...

Dec 08, 2016
popularity0 comments 0

Subscribe to rss feed